Elevated circulating aldosterone plasma levels in combination with low circulating E2 plasma levels promoted cardiac remodeling including myocardial modified Ca2+‐proteins, collagen homeostasis, and anti‐apoptotic phenotype, and moderate cardiac hypertrophy. The gene discussed is PROS1; the disease is cardiac hypertrophy.